North America Views

Pages

ERYTECH's Graspa Gains FDA ODD For AML

ERYTECH Pharma's lead product Graspa (erythrocyte-encapsulated L-asparaginase; ERY-ASP) has been granted orphan drug designation (ODD) by the FDA for the treatment of acute myeloid leukaemia (AML).

Read article ›
Pressure Rising On Deepwater Rigs

After a slowdown in the coming quarters, we expect the market for deepwater rigs to begin to recover over the medium term. Rig rates will suffer in 2014 from a slowdown in demand and a ramping up of...

Read article ›

Pages